Viveca Giongo 1, Camilly Pestana Pires de Mello 1, Felipe Mateini 1, Juliana Barbosa 2, Jussara Pinheiro Barbosa 3, Beatriz Grosso Fleury 3, Clovis Barreira e Castro 4, Angelo da Cunha Pinto 3, Izabel Christina Nunes de Palmer Paixão 1
Latency and resistance of acyclovir-resistant strains of Herpes simplex virus type 1 (HSV-1) have been associated with serious sequelae in immunocompromised individuals, such as AIDS patients. Consequently, the search for new substances with anti-HSV activity is both necessary and urgent.
To investigate whether extracts obtained from can be used in preclinical studies of drugs against herpes simplex virus type 1.
Cell viability and inhibitory drug concentrations as screening tests were used to investigate ethyl acetate and dichloromethane extracts from as antivirals.
The results of viability assays demonstrated that extracts from and showed less cytotoxicity, but only reached a very expressive CC value. In antiviral assays, showed an even more significant result of effective concentration (EC) and therapeutic index (<2.5 µg/mL and 51.6 µg/mL, respectively) compared with acyclovir (ACV).
These results demonstrated that extracts from corals have anti-herpetic activities and could contribute towards new strategies to stop the increasing incidence of resistance in herpes-related diseases.
Latência e resistência de cepas de Herpes simples tipo 1 (HSV-1) ao aciclovir têm sido associados a sequelas graves em pacientes imunocomprometidos, como pacientes com AIDS. Por essa razão, a pesquisa por novas substâncias com atividade anti-HSV-1 é uma necessidade urgente. Objetivo: Investigar se os extratos obtidos de poderiam ser usados em estudos pré-clínicos de drogas contra o vírus herpes simples tipo 1.
A viabilidade celular e concentrações inibitórias das drogas foram utilizados como testes de triagem para investigar os extratos etil acetato e diclorometano de como antivirais.
Os resultados de viabilidade demonstraram que os extratos de e não foram citotóxicas, mas somente alcançou um valor de CC expressivo. Nos ensaios antivirais, mostraram um resultado ainda mais significante de concentração efetiva (EC) e índice terapêutico (<2.5 µg/mL e 51.6 µg/mL, respectivamente) comparado com aciclovir (ACV).
Estes resultados mostram que os extratos de corais têm atividade anti-herpética e podem contribuir para novas estratégias de redução da incidência de resistência de doenças relacionadas aos herpes vírus.
Marine organisms comprise over half a million species. Due to their unusual living environment in comparison with terrestrial organisms, marine organisms produce a variety of substances, which quite often have various unprecedented chemical structures. Issues such as competition for space and predation have originated new biochemical pathways for these organisms, providing essential metabolites for their adaptation1. Over 40 novel natural product compounds are now commercially available, including antiviral products isolated from various marine organisms, which provide alternative therapeutic drugs2,3.
A literature survey revealed that Gorgonian corals have proven to be a prolific source of a variety of biologically active compounds with cytotoxic effects on human leukaemia4, such as being inhibitors of acetylcholine receptors5,6,7. The species of corals in tropical or temperate waters of the western North Atlantic are relatively well known, but those found at the south of the Amazon River are not, despite having common elements with the fauna of the Caribbean octocorals8. Silva & Pérez7, in 2002, reported 59 species of octocorals on the Brazilian coast based on the biosynthetic origin of bioactive terpenes. This classification could provide a system to produce
Almost 90% of people worldwide have one or both HSV-1 and HSV-2 viruses. In developed countries, the acquisition of HSV-1 is delayed from early childhood to adolescence or young adulthood10. Herpes simplex virus (HSV) belongs to
This study involved an evaluation of the fractions obtained from
The octocorals were collected by scuba divers in Parque Municipal Marinho de Recife de Fora, Porto Seguro, Bahia, and stored in ethanol to obtain the crude extracts.
The extracts were fixed in organic solvents of different polarities (hexane, dichloromethane, and ethyl acetate) and evaporated separately under reduced pressure.
The mass spectra of low resolution (70 ev) was obtained on a Hewlett Packard 5987A. The fragments were described by the ratio mass/charge (m/z) and their intensities expressed as a percentage of base peak (100%). The chromatographic column used was a fused silica capillary column with stationary phase HP-5 MS (5% phenyl methyl siloxane) measuring 30 m long with an internal diameter of 0.25 mm and a thickness of 0.25 µm. The samples were injected using 1 µl of the fractions, previously diluted in CH2Cl2. The chromatographic conditions were: initial column temperature: 50°C (4 min), gradient: 100C/min, final temperature of the column: 290°C (20 min), injector temperature: 270°C, detector temperature: 290°C, carrier gas: hydrogen, injection mode: flow division split 1:20.
Vero cells (African green monkey
The MTT cytotoxic assay was performed in Vero cells in 96-multiwell plates (105/well) treated with different concentrations of the crude extracts from
Monolayers of Vero cells in six-well plates were exposed to different dilutions of the supernatant from yield-reduction assays for 1 h at 37°C. Next, cells were washed with PBS and DMEM medium containing 5% FBS and then 1% methylcellulose (Fluka) (overlay medium) was added to cells. After 72 h at 37°C, the monolayers were fixed with 10% formaldehyde in PBS and stained with a 0.1% solution of crystal violet in 70% methanol, and the virus titers were calculated by scoring the plaque-forming units (PFU). Additionally, other experiments were performed in the format of a plaque-reduction assay. In those particular cases, various concentrations of the compounds were added in the overlay medium and after 72 h, cells were fixed and plaques counted.
Monolayers of Vero cells (105) in 24-well plates were infected with HSV-1 (AR-29 or KOS strain) at an MOI equal to 1 for 1 h at 37°C. Cells were washed with PBS to remove residual viruses and various concentrations of the extract in Medium 199 with 2,5% FBS were added. After 20 h, cells were lysed, cellular debris were cleared by centrifugation, and virus titers in the supernatant were determined by the plaque-forming assay using Vero cells, as described in the previous item. For comparison, linear regression of the dose response curves for ACV was also performed to calculate EC50 values.
The octocorals were collected by scuba divers in the Marine Park of Recife de Fora, Porto Seguro, Bahia, and stored in ethanol to obtain the crude extracts. Specimens were identified at Museu Nacional, UFRJ20,21. The extracts were separately prepared in organic solvents of different polarities (hexane, dichloromethane (DCM), and ethyl acetate (EtOAc)), and evaporated under reduced pressure except
Analysis by thin layer chromatography (TLC) of crude extracts of each coral revealed that hexane and DCM extracts of
For a detailed analysis, each crude extract (15 mg) was filtered on a column by adsorption on silica gel 60-70 to 230 mesh, using DCM (30 mL). After evaporation of solvents, an aliquot of each sample (1 mg/mL) was analyzed by gas chromatography-mass spectrometry (GC-MS), showing that
*Molecular ion.
Viability and antiviral activities of the octocorals fractions were identified according to the species and the solvent used for purification. Thus, P-1 corresponds to
Tests of cell viability performed in Vero cells from kidneys of African green monkeys (
The antiviral assay was performed with the fractions that showed the highest values of CC50. It has been also identified the fraction P-1.3 as the compound with antiviral activity (
*Acyclovir; **data obtained by Castro17; ***CC50=100mg/mL; a: In this assay, Vero cells were cultured in the presence of the extracts for 72 hours at 37°C; b: Antiviral assay that determined the concentration of the extract that reduces the titer of HSV-1 by 50% in Vero cell culture; c: Selectivity Index means how safe some fractions could be as antivirals as reference EC50 = 2.5 µg/mL.
Recently, the great challenge for HSV infections lies in the search for drugs that could control the development of resistance and latency, especially in AIDS patients and individuals after hematopoietic stem cell transplantation (HSCT)23. Resistance to ACV is mediated in 95% of the cases by mutations in the TK gene and in 5% of the cases by mutations in the DNA pol gene, resulting in the alteration of enzyme activity15,24.
Genotyping findings confirmed that the UL23 TK gene of HSV-1 has an uncommonly high polymorphism15,25. The recently discovered inhibitors of the HSV helicase-primase are the most potent development candidates today, but they depend on long-term studies26.
Marine sponges are considered notable sources of bioactive compounds found in the marine environment. The most important antiviral reported so far is the nucleoside Ara-A (vidarabine), isolated from the sponge Tethya crypta. It inhibits viral DNA polymerase and DNA synthesis of herpes, vaccinia, and varicella zoster viruses27. In our study we analysed crude extracts, believing that natural products have great relevance in pharmacology due to their high chemical diversity. The purification of P. regia and P. grandiflora extracts revealed fatty acid esters as common substances for both algae. Additionally, it is consistent with previous antiviral studies that showed that fatty acid esters, specially C14 and C15 isoforms, are able to inactivate enveloped viruses like herpes28. These bioactive molecules are often secondary metabolites, whose main function is to enable and/or modulate cellular communication and defence.
The highest antiviral activity for HSV-1 was obtained by
IZABEL CHRISTINA NUNES DE PALMER PAIXÃO Universidade Federal Fluminense, Instituto de Biologia Rua Outeiro de São João s/n - Campus do Valonguinho, Centro Niterói (RJ), Brazil CEP: 24020-141 E-mail: izabeluff@gmail.com
Received: 13/03/2016
Accepted: 21/04/2016